Author Login IJIRT Partner Network (IPN) Login

An overview on various nano- formulations of resveratrol in combination with different drugs for the treatment of HCC

  • Unique Paper ID: 159131
  • Volume: 9
  • Issue: 11
  • PageNo: 586-597
  • Abstract:
  • Liver cancer remains a serious threat to global health, and its prevalence is increasing worldwide. Its causes include, among other factors, exposure to the C or B hepatitis viruses, alcohol use, smoking, obesity, nonalcoholic fatty liver disease, diabetes, and oxidative stress. There are other primary liver cancer types, but hepatocellular carcinoma will be our main focus (HCC). Naturally occurring bioactive food components such as polyphenolic compounds, for example, have demonstrated good antioxidant activity and show promise for use in the prevention of cancer. Since it has a broad spectrum of medicinal activities, including its anticancer, anti-inflammatory, and antioxidant properties, resveratrol, a natural polyphenol and phytoalexin, has received a lot of interest in the last 10 years. It has been shown that resveratrol suppressed HCC cell growth in a dose-dependent manner in both anchorage-dependent and independent conditions. However, its limited therapeutic value is due to its weak water solubility, poor chemical stability, and short biological half-life. Poor pharmacokinetics and low potency appear to be the two main bottlenecks of resveratrol among the many restrictions. To accelerate the transition of resveratrol from the laboratory to the bedside, new perspectives and tactics have been put forth. The most promising strategy in the meantime is to improve resveratrol bioavailability through novel formulations. As an alternative, stronger resveratrol analogues could be created to increase the substance’s anticancer effectiveness. The physicochemical features of resveratrol, the therapeutic potential of resveratrol nano-formulations, and the anticancer efficacy of resveratrol encapsulated n nanoparticles on hepatocarcinoma and various malignancies are the key topics of this paper.
Download article email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 9
  • Issue: 11
  • PageNo: 586-597

An overview on various nano- formulations of resveratrol in combination with different drugs for the treatment of HCC

Related Articles

Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry